AlloDx Presents Organ Transplant Liquid Biopsy Research at ATC 2018

The American Transplant Congress (ATC) was held in Seattle, USA from June 1-6, 2018. The company's Dr. Yang Gongda was invited to participate in this grand event in the field of global organ transplantation, and presented the team's latest scientific research results "Noninvasive Detection of Infection and Rejection in Renal Transplant Patients" at the conference, which received widespread attention and unanimous recognition from the experts present. This indicates that the company's various indicators of rejection and infection products are at the leading international level. The American Organ Transplantation Conference (ATC), the European Organ Transplantation Conference (ESOT), and the International Organ Transplantation Society (TTS) are currently the three most prestigious international organ transplantation academic organizations in the world. Each conference is a showcase for the most cutting-edge research results in the field of organ transplantation. Rejection and infection in transplant patients are the main causes of graft failure. Accurate, non-invasive and real-time clinical diagnosis is very necessary. After more than 2 years of process research and development optimization, case collection and clinical follow-up, the company has built a rejection and infection database for the Chinese transplant population for the first time.

This study is one of the few domestic research results included in the conference. It contributes to basic research in the field of organ transplantation in my country and strives to open a new era of organ transplantation research in China.